Chainarong Tocharus Selected Research

hexahydrocurcumin

1/2022	Hexahydrocurcumin ameliorates hypertensive and vascular remodeling in L-NAME-induced rats.
6/2020	Hexahydrocurcumin alleviated blood-brain barrier dysfunction in cerebral ischemia/reperfusion rats.
1/2017	Hexahydrocurcumin protects against cerebral ischemia/reperfusion injury, attenuates inflammation, and improves antioxidant defenses in a rat stroke model.
12/2012	Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.
5/2012	Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chainarong Tocharus Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 07/2015
10	Brain Ischemia (Cerebral Ischemia) 11/2022 - 01/2017
7	Infarction (Infarctions) 02/2022 - 01/2017
6	Reperfusion Injury 11/2022 - 01/2017
6	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 01/2016
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2022 - 01/2020
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2014
5	Neuroblastoma 01/2021 - 01/2015
4	Cognitive Dysfunction 01/2022 - 01/2020
4	Atherosclerosis 08/2021 - 03/2016
3	Neuroinflammatory Diseases 01/2022 - 07/2015
3	Hypertension (High Blood Pressure) 01/2022 - 12/2019
3	Glioma (Gliomas) 01/2017 - 04/2014
2	Ischemia 11/2022 - 01/2020
2	Gliosis 01/2022 - 03/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 10/2016
2	Ischemic Stroke 01/2021 - 01/2017
2	Obesity 01/2021 - 07/2019
2	Insulin Resistance 07/2020 - 07/2019
2	Body Weight (Weight, Body) 05/2020 - 12/2019
2	Amyloid Plaque 01/2016 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 12/2012 - 05/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Vascular Remodeling 01/2022
1	Hyperlipidemias (Hyperlipidemia) 08/2021
1	Non-alcoholic Fatty Liver Disease 07/2020
1	Hypoxia (Hypoxemia) 05/2020
1	Cerebral Infarction 01/2020

Drug/Important Bio-Agent (IBA)

9	MelatoninIBA 01/2022 - 04/2014
6	AntioxidantsIBA 01/2022 - 07/2015
5	hexahydrocurcuminIBA 01/2022 - 05/2012
4	agomelatine (S20098)IBA 02/2022 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2015
4	Neuroprotective AgentsIBA 01/2022 - 09/2018
4	Amyloid (Amyloid Fibrils)IBA 04/2021 - 01/2015
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2017 - 04/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
3	cyanidinIBA 09/2018 - 12/2014
2	morinIBA 02/2022 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 04/2021
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2022 - 01/2017
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 12/2019
2	CurcuminIBA 01/2022 - 06/2020
2	neferineIBA 12/2021 - 05/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 01/2020
2	Amyloid beta-PeptidesIBA 01/2021 - 07/2018
2	GlucocorticoidsIBA 12/2020 - 01/2020
2	nonivamideIBA 07/2020 - 07/2019
2	Evans Blue (Blue, Evans)FDA Link 06/2020 - 01/2017
2	dihydrocapsaicinIBA 05/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 12/2019 - 04/2014
2	Peptides (Polypeptides)IBA 07/2018 - 01/2016
2	Angiotensin IIIBA 10/2016 - 03/2016
2	cyanidin-3-O-beta-glucopyranosideIBA 10/2016 - 03/2016
2	Atorvastatin (Lipitor)FDA Link 09/2016 - 03/2016
2	demethylcurcuminIBA 01/2016 - 01/2015
2	DiarylheptanoidsIBA 01/2016 - 09/2015
2	Fluorouracil (Carac)FDA LinkGeneric 12/2012 - 05/2012
1	HMGB1 Protein (HMG1)IBA 11/2022
1	CateninsIBA 02/2022
1	Advanced Glycation End ProductsIBA 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	Aluminum ChlorideIBA 01/2022
1	flavan-3-olIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	CollagenIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	arginine methyl esterIBA 01/2022
1	CalciumIBA 12/2021
1	Nimodipine (Modus)FDA LinkGeneric 12/2021
1	InflammasomesIBA 08/2021
1	oxidized low density lipoproteinIBA 08/2021
1	tau Proteins (tau Protein)IBA 04/2021
1	LipidsIBA 07/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	triphenyltetrazoliumIBA 05/2020
1	Angiogenesis InhibitorsIBA 05/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2020
1	salicylhydroxamic acid (SHAM)IBA 05/2020
1	Metalloproteases (Metalloproteinases)IBA 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Angiopoietin-1IBA 05/2020
1	IntegrinsIBA 03/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	CytokinesIBA 03/2020
1	NF-kappa B (NF-kB)IBA 03/2020
1	Toll-Like Receptor 4IBA 01/2020
1	Vasodilator Agents (Vasodilators)IBA 12/2019
1	Enalapril FDA LinkGeneric 12/2019
1	Rosmarinic AcidIBA 12/2019
1	Dihydrotachysterol (AT 10)IBA 12/2019
1	EstersIBA 12/2019

Therapy/Procedure

3	Therapeutics 07/2019 - 04/2012
1	Intraperitoneal Injections 01/2020